Parvati B. Patel

1.1k total citations
23 papers, 371 citations indexed

About

Parvati B. Patel is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Parvati B. Patel has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Toxicology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Geriatrics and Gerontology. Recurrent topics in Parvati B. Patel's work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (7 papers). Parvati B. Patel is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (7 papers). Parvati B. Patel collaborates with scholars based in India and United States. Parvati B. Patel's co-authors include Tejas Patel, Manish Barvaliya, Viren N. Naik, CB Tripathi, Bhavesh D. Kevadiya, Saurabh Shah, C. B. Tripathi, Surekha Kishore, Chandra Bhushan Tripathi and David Trueman and has published in prestigious journals such as European Journal of Clinical Pharmacology, Value in Health and European Journal of Obstetrics & Gynecology and Reproductive Biology.

In The Last Decade

Parvati B. Patel

22 papers receiving 354 citations

Peers

Parvati B. Patel
Jay P. Rho United States
Sarah Pontefract United Kingdom
P Mishra India
Parvati B. Patel
Citations per year, relative to Parvati B. Patel Parvati B. Patel (= 1×) peers Andreea Farcaș

Countries citing papers authored by Parvati B. Patel

Since Specialization
Citations

This map shows the geographic impact of Parvati B. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvati B. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvati B. Patel more than expected).

Fields of papers citing papers by Parvati B. Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvati B. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvati B. Patel. The network helps show where Parvati B. Patel may publish in the future.

Co-authorship network of co-authors of Parvati B. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Parvati B. Patel. A scholar is included among the top collaborators of Parvati B. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parvati B. Patel. Parvati B. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Tejas, et al.. (2022). Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis. European Journal of Clinical Pharmacology. 79(1). 99–116. 9 indexed citations
2.
Patel, Tejas, et al.. (2021). Implementation of Objective Structured Practical Examination in Formative Assessment for Undergraduate Practical Pharmacology. MAEDICA – a Journal of Clinical Medicine. 16(1). 2 indexed citations
3.
Patel, Tejas, et al.. (2021). Drug-related deaths among inpatients: a meta-analysis. European Journal of Clinical Pharmacology. 78(2). 267–278. 7 indexed citations
4.
Patel, Tejas, et al.. (2021). Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials. Journal of Infection and Public Health. 14(6). 740–748. 49 indexed citations
5.
Patel, Tejas, et al.. (2021). Comparison of effectiveness of interventions in reducing mortality in patients of toxic epidermal necrolysis: A network meta-analysis. Indian Journal of Dermatology Venereology and Leprology. 87(5). 628–644. 14 indexed citations
6.
Patel, Tejas, et al.. (2020). Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review. Journal of Neuroimmune Pharmacology. 15(3). 349–349. 9 indexed citations
7.
Patel, Tejas, et al.. (2020). Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review. Journal of Neuroimmune Pharmacology. 15(3). 350–358. 20 indexed citations
8.
Patel, Parvati B. & Tejas Patel. (2019). Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis. European Journal of Clinical Pharmacology. 75(9). 1293–1307. 16 indexed citations
9.
Patel, Tejas & Parvati B. Patel. (2018). Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. European Journal of Clinical Pharmacology. 74(6). 819–832. 54 indexed citations
10.
Patel, Parvati B., et al.. (2017). Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India – a cross-sectional study. International Journal of Psychiatry in Clinical Practice. 22(2). 101–108. 9 indexed citations
11.
Patel, Tejas, et al.. (2016). Hospitalizations due to preventable adverse reactions—a systematic review. European Journal of Clinical Pharmacology. 73(4). 385–398. 49 indexed citations
12.
Patel, Tejas, et al.. (2016). Perceptions of the Use of Blueprinting in a Formative Theory Assessment in Pharmacology Education. Sultan Qaboos University medical journal. 16(4). e475–481. 1 indexed citations
14.
Patel, Tejas, et al.. (2015). Adverse drug reactions in a psychiatric department of tertiary care teaching hospital in India: Analysis of spontaneously reported cases. Asian Journal of Psychiatry. 17. 42–49. 14 indexed citations
15.
Patel, Parvati B., et al.. (2015). Efficacy and safety of lornoxicam vs ibuprofen in primary dysmenorrhea: a randomized, double-blind, double dummy, active-controlled, cross over study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 188. 118–123. 9 indexed citations
16.
Patel, Tejas & Parvati B. Patel. (2015). Incidence of Adverse Drug Reactions in Indian Hospitals: A Systematic Review of Prospective Studies. Current Drug Safety. 11(2). 128–136. 40 indexed citations
17.
Patel, Tejas, Parvati B. Patel, Manish Barvaliya, & C. B. Tripathi. (2014). Drug-induced anaphylactic reactions in Indian population: A systematic review. Indian Journal of Critical Care Medicine. 18(12). 796–806. 12 indexed citations
18.
Patel, Tejas, et al.. (2014). Adverse drug reactions in a tertiary care teaching hospital in India: analysis of spontaneously reported cases. International Journal of Basic & Clinical Pharmacology. 1078–1078. 17 indexed citations
19.
Patel, Parvati B., et al.. (2011). Hepatotoxicity Studies of Nimesulide in Litters of Rat. National journal of integrated research in medicine. 2(1). 16–21. 3 indexed citations
20.
Patel, Parvati B., et al.. (2011). Antitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs. Journal of Pharmacology and Pharmacotherapeutics. 2(4). 253–260. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026